Cardio Diagnostics Holdings, Inc. Amortization of Acquisition Costs
Cardio Diagnostics Holdings, Inc. (CDIO) reported Amortization of Acquisition Costs of $802 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfAcquisitionCosts · last filed 2024-11-13
- Cardio Diagnostics Holdings, Inc. amortization of acquisition costs for the quarter ending 2024-09-30 was $802.00, a 0.00% change year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization of acquisition costs for the quarter ending 2024-06-30 was $794.00, a 0.13% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization of acquisition costs for the quarter ending 2024-03-31 was $793.00, a 1.02% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization of acquisition costs for the quarter ending 2023-12-31 was $802.00.
- Cardio Diagnostics Holdings, Inc. amortization of acquisition costs for fiscal 2023 was $3.18K.
| Period end | Amortization of Acquisition Costs 3 month | Amortization of Acquisition Costs 6 month | Amortization of Acquisition Costs 9 month | Amortization of Acquisition Costs 12 month |
|---|---|---|---|---|
| 2024-09-30 | $802.00 10-Q · filed 2024-11-13 | $1.60K derived: sum of 2 quarters · filed 2024-11-13 | $2.39K 10-Q · filed 2024-11-13 | $3.19K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $794.00 10-Q · filed 2024-08-12 | $1.59K 10-Q · filed 2024-08-12 | $2.39K derived: sum of 3 quarters · filed 2024-08-12 | $3.19K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $793.00 10-Q · filed 2024-05-15 | $1.59K derived: sum of 2 quarters · filed 2024-05-15 | $2.40K derived: sum of 3 quarters · filed 2024-11-13 | $3.19K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $802.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.60K derived: sum of 2 quarters · filed 2024-11-13 | $2.40K derived: sum of 3 quarters · filed 2024-11-13 | $3.18K 10-K · filed 2024-04-01 |
| 2023-09-30 | $802.00 10-Q · filed 2024-11-13 | $1.59K derived: sum of 2 quarters · filed 2024-11-13 | $2.38K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $793.00 10-Q · filed 2024-08-12 | $1.58K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $785.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |